- Home
- PTN vs BFRG Comparison
PTN vs BFRG Comparison
Compare PTN & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTN
- BFRG
- Stock Information
- Founded
- PTN 1986
- BFRG 2017
- Country
- PTN United States
- BFRG United States
- Employees
- PTN N/A
- BFRG N/A
- Industry
- PTN Biotechnology: Pharmaceutical Preparations
- BFRG Retail: Computer Software & Peripheral Equipment
- Sector
- PTN Health Care
- BFRG Technology
- Exchange
- PTN Nasdaq
- BFRG Nasdaq
- Market Cap
- PTN 25.4M
- BFRG 21.2M
- IPO Year
- PTN 1993
- BFRG 2023
- Fundamental
- Price
- PTN $1.06
- BFRG $2.12
- Analyst Decision
- PTN Strong Buy
- BFRG
- Analyst Count
- PTN 1
- BFRG 0
- Target Price
- PTN $17.00
- BFRG N/A
- AVG Volume (30 Days)
- PTN 570.9K
- BFRG 268.4K
- Earning Date
- PTN 02-13-2025
- BFRG 11-08-2024
- Dividend Yield
- PTN N/A
- BFRG N/A
- EPS Growth
- PTN N/A
- BFRG N/A
- EPS
- PTN N/A
- BFRG N/A
- Revenue
- PTN $2,384,113.00
- BFRG N/A
- Revenue This Year
- PTN N/A
- BFRG N/A
- Revenue Next Year
- PTN N/A
- BFRG N/A
- P/E Ratio
- PTN N/A
- BFRG N/A
- Revenue Growth
- PTN N/A
- BFRG 550.00
- 52 Week Low
- PTN $0.68
- BFRG $1.43
- 52 Week High
- PTN $5.65
- BFRG $8.35
- Technical
- Relative Strength Index (RSI)
- PTN 47.60
- BFRG 46.31
- Support Level
- PTN $1.06
- BFRG $2.02
- Resistance Level
- PTN $1.20
- BFRG $2.24
- Average True Range (ATR)
- PTN 0.14
- BFRG 0.23
- MACD
- PTN -0.01
- BFRG -0.01
- Stochastic Oscillator
- PTN 7.14
- BFRG 22.67
About PTN Palatin Technologies Inc.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.